Schizophrenia Treatment Adherence Investigation (STAI)

The primary objective of this treatment review and feedback program is to quantify the risk status for medication adherence in a cohort of Australian patients diagnosed with schizophrenia.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Schizophrenia Mental Disorders Psychotic Disorders Schizoaffective Disorder Schizophrenia Spectrum and Other Psychotic Disorders

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

About this study

The primary objective of this treatment review and feedback program is to quantify the risk status for medication adherence in a cohort of Australian patients diagnosed with schizophrenia. Observational study - no study drug administered

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Clinical diagnosis of schizophrenia or schizoaffective disorder according to DSM-IV
Currently treated in an outpatient clinic
Able to provide informed consent
Concurrent enrolment in clinical trials is acceptable
Have completed all questions on the Drug Attitude Inventory (DAI-10) and Medication Adherence Rating Scale (MARS) survey

Exclusion criteria

Treatment and study plan

Risk status for medication adherence

Other

Examination of risk status for medication adherence in a cohort of Australian patients diagnosed with schizophrenia

Primary outcomes

Primary outcome measure is the Clinical Assessment of Adherence as rated by the Investigators

Time frame: 6 months, 12 months

Secondary outcomes

Clinical exacerbations (worsening of symptoms)

Time frame: 6 mths, 12 mths
Medication changes

Time frame: 6 mths, 12 mths

Sponsors and collaborators

Lead sponsor

Janssen-Cilag Pty Ltd

Industry

Registry information

Official study title

Clinical Audit and Feedback Program to Determine Risk for Medication Adherence in Outpatients Diagnosed With Schizophrenia in Australia

Important dates

Study start: 2007
Primary completion: 2009
Study completion: 2009
First posted: Oct 26, 2009
Registry last updated: Apr 9, 2014

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed